Caroline Genco

Caroline Genco
Provost of Tufts University
Incumbent
Assumed office January 1, 2022
Preceded by	Nadine Aubry
Personal details
Born	Caroline Attardo
Alma mater	State University of New York at Fredonia University of Rochester
Scientific career
Fields	Microbiology, immunology
Institutions	Emory University Morehouse School of Medicine Boston University School of Medicine Tufts University School of Medicine
Thesis	Transfer of antibiotic resistance in Gram- negative bacteria  (1987)

Caroline Attardo Genco is an American microbiologist and academic administrator. She is Arthur E. Spiller Professor in Genetics at Tufts University School of Medicine, and provost of Tufts University.

Life and career

Genco was born to Rita Galletti and Charles Attardo. She was the first member of her family to attend college, completing a B.S. in biology at State University of New York at Fredonia in 1981, and then an M.S. in microbiology from the University of Rochester in 1984. She received her PhD, also at the University of Rochester, in 1987, studying Neisseria gonorrhoeae antibiotic resistance.

Following her graduate studies, Genco completed a post-doc at the Centers for Disease Control and Prevention. Then, in 1989, she was appointed to an assistant professor position at Emory University, before joining the faculty of Morehouse School of Medicine as an associate professor in 1991. From 1997 to 2015, Genco served as Professor of Medicine at the Boston University School of Medicine, where she researched the link between oral bacteria and heart diseases.

In 2015, Genco joined the Tufts University School of Medicine as the Arthur E. Spiller Professor in Genetics and chair of the Department of Immunology. In 2019, she became vice provost for research. She succeeded Nadine Aubry as provost and senior vice president ad interim of Tufts University on January 1, 2022, and was appointed to those positions on a permanent basis on August 1, 2023.

Research

At Tufts, Genco's laboratory researches how the microbiome and innate immune system influence inflammatory diseases. One specific research area of the lab is how mucosal pathogens work to evade macrophages/monocytes and the innate immune response in general. Genco's lab has recently progressed this work from in vitro human tissue culture to in vivo mouse models, and now human cohorts.

Another research focus of Genco's group is how Neisseria bacteria regulate gene transcription, with a focus on how environmental factors influence these pathways. Specifically, the lab has uncovered some of the mechanisms by which Fur (ferric uptake regulator), a regulatory protein, affects the virulence of bacteria.

Genco maintains a particular interest in antibiotic resistance and immune response to Neisseria gonorrhoeae, and especially how these differ in male and female human hosts. Genco's laboratory was one of the first to examine gonorrhea in female patients, and how their typically asymptomatic infections differed from males' typically symptomatic ones. Further, in 2023, Genco co-chaired the 23rd annual International Pathogenic Neisseria Conference (IPNC).